肿瘤缓解分级和ERCC1核蛋白表达可以预测胃食管肿瘤患者新辅助化疗的临床效果
Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy
肿瘤缓解分级和ERCC1核蛋白表达可以预测胃食管肿瘤患者新辅助化疗的临床效果 |
|
评价者：徐建明 |
Tumour Regression and ERCC1 Nuclear Protein Expression Predict Clinical Outcome in Patients with Gastro-Oesophageal Cancer Treated with Neoadjuvant Chemotherapy |
| 图1 干预措施流程图 |
| |